Skip to main content
Erschienen in: Neuroradiology 7/2013

01.07.2013 | Diagnostic Neuroradiology

Quantitative MRI shows cerebral microstructural damage in hemolytic–uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI

verfasst von: Karin Weissenborn, Eva Bültmann, Frank Donnerstag, Anja M. Giesemann, Friedrich Götz, Hans Worthmann, Meike Heeren, Jan Kielstein, Anke Schwarz, Heinrich Lanfermann, Xiao-Qi Ding

Erschienen in: Neuroradiology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Severe neurological symptoms in Shiga toxin-producing Escherichia coli infection associated hemolytic–uremic syndrome (STEC–HUS) are often accompanied by none or only mild alterations of cerebral magnetic resonance imaging (MRI). This study aims to analyze if quantitative MRI is able to reveal cerebral pathological alterations invisible for conventional MRI.

Methods

In nine patients with STEC–HUS associated severe neurological symptoms but inconspicuous cerebral MRI findings maps of the parameters T2 relaxation time, relative proton density (PD), apparent diffusion coefficient (ADC), and fractional anisotropy (FA) were generated. Quantitative values of these parameters were measured at the basal ganglia, thalamus, and white matter of the frontal and parietal lobe and compared to those of nine age- and sex-matched controls.

Results

Significant T2 prolongation (p < 0.01) was found in the basal ganglia of all patients compared to controls. PD and ADC were not significantly altered. A significant reduction of FA in patients was seen at caput nuclei caudati (p < 0.01).

Conclusion

Prolonged T2 relaxation time indicates cerebral microstructural damages in these patients despite their inconspicuous MRI findings. T2 relaxometry could be used as a complementary tool for the assessment of metabolic–toxic brain syndromes.
Literatur
1.
Zurück zum Zitat Roche-Martinez A, Poo P, Maristany-Cucurella M, Jimenez-Llort A, Camacho JA, Campistol J (2008) Neurologic presentation in haemolytic–uraemic syndrome. Rev Neurol 47(4):191–196PubMed Roche-Martinez A, Poo P, Maristany-Cucurella M, Jimenez-Llort A, Camacho JA, Campistol J (2008) Neurologic presentation in haemolytic–uraemic syndrome. Rev Neurol 47(4):191–196PubMed
2.
Zurück zum Zitat Eriksson KJ, Boyd SG, Tasker RC (2001) Acute neurology and neurophysiology of haemolytic–uraemic syndrome. Arch Dis Child 84(5):434–435PubMedCrossRef Eriksson KJ, Boyd SG, Tasker RC (2001) Acute neurology and neurophysiology of haemolytic–uraemic syndrome. Arch Dis Child 84(5):434–435PubMedCrossRef
3.
Zurück zum Zitat Gallo EG, Gianantonio CA (1995) Extrarenal involvement in diarrhoea-associated haemolytic–uraemic syndrome. Pediatr Nephrol 9(1):117–119PubMedCrossRef Gallo EG, Gianantonio CA (1995) Extrarenal involvement in diarrhoea-associated haemolytic–uraemic syndrome. Pediatr Nephrol 9(1):117–119PubMedCrossRef
4.
Zurück zum Zitat Keir L, Coward RJ (2011) Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatrics 26(4):523–533, Epub 2010 Keir L, Coward RJ (2011) Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatrics 26(4):523–533, Epub 2010
5.
Zurück zum Zitat Zoja C, Buelli S, Morigi M (2010) Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatrics 25(11):2231–2240, Epub 2010 Apr 2228 Zoja C, Buelli S, Morigi M (2010) Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatrics 25(11):2231–2240, Epub 2010 Apr 2228
6.
Zurück zum Zitat Bale JF Jr, Brasher C, Siegler RL (1980) CNS manifestations of the hemolytic–uremic syndrome. Relationship to metabolic alterations and prognosis. Am J Dis Child 134(9):869–872PubMed Bale JF Jr, Brasher C, Siegler RL (1980) CNS manifestations of the hemolytic–uremic syndrome. Relationship to metabolic alterations and prognosis. Am J Dis Child 134(9):869–872PubMed
7.
Zurück zum Zitat Obata F (2010) Influence of Escherichia coli shiga toxin on the mammalian central nervous system. Adv Appl Microbiol 71:1–19PubMedCrossRef Obata F (2010) Influence of Escherichia coli shiga toxin on the mammalian central nervous system. Adv Appl Microbiol 71:1–19PubMedCrossRef
8.
Zurück zum Zitat Magnus T, Röther J, Simova O, Meier-Cillien M, Repenthin J, Möller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl RK, Wegscheider K, Urban P, Eckert B, Glatzel M, Fiehler J, Gerloff C (2012) The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 135(Pt 6):1850–1859PubMedCrossRef Magnus T, Röther J, Simova O, Meier-Cillien M, Repenthin J, Möller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl RK, Wegscheider K, Urban P, Eckert B, Glatzel M, Fiehler J, Gerloff C (2012) The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 135(Pt 6):1850–1859PubMedCrossRef
9.
Zurück zum Zitat Weissenborn K, Donnerstag F, Kielstein JT, Heeren M, Worthmann H, Hecker H, Schmitt R, Schiffer M, Pasedag T, Schuppner R, Tryc AB, Raab P, Hartmann H, Ding XQ, Hafer C, Menne J, Schmidt BM, Bultmann E, Haller H, Dengler R, Lanfermann H, Giesemann AM (2012) Neurologic manifestations of E. coli infection-induced hemolytic–uremic syndrome in adults. Neurology 79(14):1466–1473PubMedCrossRef Weissenborn K, Donnerstag F, Kielstein JT, Heeren M, Worthmann H, Hecker H, Schmitt R, Schiffer M, Pasedag T, Schuppner R, Tryc AB, Raab P, Hartmann H, Ding XQ, Hafer C, Menne J, Schmidt BM, Bultmann E, Haller H, Dengler R, Lanfermann H, Giesemann AM (2012) Neurologic manifestations of E. coli infection-induced hemolytic–uremic syndrome in adults. Neurology 79(14):1466–1473PubMedCrossRef
10.
Zurück zum Zitat Upadhyaya K, Barwick K, Fishaut M, Kashgarian M, Siegel NJ (1980) The importance of nonrenal involvement in hemolytic–uremic syndrome. Pediatrics 65(1):115–120PubMed Upadhyaya K, Barwick K, Fishaut M, Kashgarian M, Siegel NJ (1980) The importance of nonrenal involvement in hemolytic–uremic syndrome. Pediatrics 65(1):115–120PubMed
11.
Zurück zum Zitat Steinborn M, Leiz S, Rudisser K, Griebel M, Harder T, Hahn H (2004) CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol 34(10):805–810PubMedCrossRef Steinborn M, Leiz S, Rudisser K, Griebel M, Harder T, Hahn H (2004) CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol 34(10):805–810PubMedCrossRef
12.
Zurück zum Zitat Ohlmann D, Hamann GF, Hassler M, Schimrigk K (1996) Involvement of the central nervous system in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. Nervenarzt 67(10):880–882PubMedCrossRef Ohlmann D, Hamann GF, Hassler M, Schimrigk K (1996) Involvement of the central nervous system in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. Nervenarzt 67(10):880–882PubMedCrossRef
13.
Zurück zum Zitat Ding XQ, Sun Y, Kruse B, Illies T, Zeumer H, Fiehler J, Lanfermann H (2009) Microstructural callosal abnormalities in normal-appearing brain of children with developmental delay detected with diffusion tensor imaging. Eur Radiol 19(6):1537–1543PubMedCrossRef Ding XQ, Sun Y, Kruse B, Illies T, Zeumer H, Fiehler J, Lanfermann H (2009) Microstructural callosal abnormalities in normal-appearing brain of children with developmental delay detected with diffusion tensor imaging. Eur Radiol 19(6):1537–1543PubMedCrossRef
14.
Zurück zum Zitat Ding XQ, Fiehler J, Kohlschutter B, Wittkugel O, Grzyska U, Zeumer H, Ullrich K (2008) MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients. J Magn Reson Imaging 27(5):998–1004PubMedCrossRef Ding XQ, Fiehler J, Kohlschutter B, Wittkugel O, Grzyska U, Zeumer H, Ullrich K (2008) MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients. J Magn Reson Imaging 27(5):998–1004PubMedCrossRef
15.
Zurück zum Zitat Ding XQ, Wittkugel O, Goebell E, Förster AF, Grzyska U, Zeumer H, Fiehler J (2008) Clinical applications of quantitative T2 determination: a complementary MRI tool for routine diagnosis of suspected myelination disorders. Eur J Paediatr Neurol 12(4):298–308, Epub 2007 OctPubMedCrossRef Ding XQ, Wittkugel O, Goebell E, Förster AF, Grzyska U, Zeumer H, Fiehler J (2008) Clinical applications of quantitative T2 determination: a complementary MRI tool for routine diagnosis of suspected myelination disorders. Eur J Paediatr Neurol 12(4):298–308, Epub 2007 OctPubMedCrossRef
16.
Zurück zum Zitat Leppert IR, Almli CR, McKinstry RC, Mulkern RV, Pierpaoli C, Rivkin MJ, Pike GB (2009) T(2) relaxometry of normal pediatric brain development. J Magn Reson Imaging 29(2):258–267PubMedCrossRef Leppert IR, Almli CR, McKinstry RC, Mulkern RV, Pierpaoli C, Rivkin MJ, Pike GB (2009) T(2) relaxometry of normal pediatric brain development. J Magn Reson Imaging 29(2):258–267PubMedCrossRef
17.
Zurück zum Zitat Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophoton Int 11(7):36–42 Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophoton Int 11(7):36–42
18.
Zurück zum Zitat Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Piètrement C, Champion G, Ulinski T, Deschênes G (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5(7):1218–1228PubMedCrossRef Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Piètrement C, Champion G, Ulinski T, Deschênes G (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5(7):1218–1228PubMedCrossRef
19.
Zurück zum Zitat Donnerstag F, Ding X, Pape L, Bültmann E, Lücke T, Zajaczek J, Hoy L, Das AM, Lanfermann H, Ehrich J, Hartmann H (2012) Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement. Eur Radiol 22(3):506–513PubMedCrossRef Donnerstag F, Ding X, Pape L, Bültmann E, Lücke T, Zajaczek J, Hoy L, Das AM, Lanfermann H, Ehrich J, Hartmann H (2012) Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement. Eur Radiol 22(3):506–513PubMedCrossRef
20.
Zurück zum Zitat Ono J, Kodaka R, Imai K, Itagaki Y, Tanaka J, Inui K, Nagai T, Sakurai K, Harada K, Okada S (1993) Evaluation of myelination by means of the T2 value on magnetic resonance imaging. Brain Dev 15(6):433–438PubMedCrossRef Ono J, Kodaka R, Imai K, Itagaki Y, Tanaka J, Inui K, Nagai T, Sakurai K, Harada K, Okada S (1993) Evaluation of myelination by means of the T2 value on magnetic resonance imaging. Brain Dev 15(6):433–438PubMedCrossRef
21.
Zurück zum Zitat Ding XQ, Kucinski T, Wittkugel O, Goebell E, Grzyska U, Görg M, Kohlschütter A, Zeumer H (2004) Normal brain maturation characterized with age-related T2 relaxation times: an attempt to develop a quantitative imaging measure for clinical use. Invest Radiol 39(12):740–746PubMedCrossRef Ding XQ, Kucinski T, Wittkugel O, Goebell E, Grzyska U, Görg M, Kohlschütter A, Zeumer H (2004) Normal brain maturation characterized with age-related T2 relaxation times: an attempt to develop a quantitative imaging measure for clinical use. Invest Radiol 39(12):740–746PubMedCrossRef
22.
Zurück zum Zitat Bick U, Ullrich K, Stöber U, Möller H, Schuierer G, Ludolph AC, Oberwittler C, Weglage J, Wendel U (1993) White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr 152(12):1012–1020PubMedCrossRef Bick U, Ullrich K, Stöber U, Möller H, Schuierer G, Ludolph AC, Oberwittler C, Weglage J, Wendel U (1993) White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr 152(12):1012–1020PubMedCrossRef
23.
Zurück zum Zitat Larocque MP, Syme A, Yahya A, Wachowicz K, Allalunis-Turner J, Fallone BG (2010) Monitoring T2 and ADC at 9.4 T following fractionated external beam radiation therapy in a mouse model. Phys Med Biol 55(5):1381–1393PubMedCrossRef Larocque MP, Syme A, Yahya A, Wachowicz K, Allalunis-Turner J, Fallone BG (2010) Monitoring T2 and ADC at 9.4 T following fractionated external beam radiation therapy in a mouse model. Phys Med Biol 55(5):1381–1393PubMedCrossRef
24.
Zurück zum Zitat Cieszanowski A, Anysz-Grodzicka A, Szeszkowski W, Kaczynski B, Maj E, Gornicka B, Grodzicki M, Grudzinski IP, Stadnik A, Krawczyk M, Rowinski O (2012) Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol 22(11):2514–2524PubMedCrossRef Cieszanowski A, Anysz-Grodzicka A, Szeszkowski W, Kaczynski B, Maj E, Gornicka B, Grodzicki M, Grudzinski IP, Stadnik A, Krawczyk M, Rowinski O (2012) Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol 22(11):2514–2524PubMedCrossRef
25.
Zurück zum Zitat Madler B, Drabycz SA, Kolind SH, Whittall KP, MacKay AL (2008) Is diffusion anisotropy an accurate monitor of myelination? Correlation of multicomponent T2 relaxation and diffusion tensor anisotropy in human brain. Magn Reson Imaging 26(7):874–888PubMedCrossRef Madler B, Drabycz SA, Kolind SH, Whittall KP, MacKay AL (2008) Is diffusion anisotropy an accurate monitor of myelination? Correlation of multicomponent T2 relaxation and diffusion tensor anisotropy in human brain. Magn Reson Imaging 26(7):874–888PubMedCrossRef
26.
Zurück zum Zitat Bauwens A, Bielaszewska M, Kemper B, Langehanenberg P, von Bally G, Reichelt R, Mulac D, Humpf HU, Friedrich AW, Kim KS, Karch H, Müthing J (2011) Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells. Thromb Haemost 105(3):515–528PubMedCrossRef Bauwens A, Bielaszewska M, Kemper B, Langehanenberg P, von Bally G, Reichelt R, Mulac D, Humpf HU, Friedrich AW, Kim KS, Karch H, Müthing J (2011) Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells. Thromb Haemost 105(3):515–528PubMedCrossRef
27.
Zurück zum Zitat Takahashi K, Funata N, Ikuta F, Sato S (2008) Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J Neuroinflammation 5:11PubMedCrossRef Takahashi K, Funata N, Ikuta F, Sato S (2008) Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J Neuroinflammation 5:11PubMedCrossRef
28.
Zurück zum Zitat Goldstein J, Loidl CF, Creydt VP, Boccoli J, Ibarra C (2007) Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res 1161:106–115PubMedCrossRef Goldstein J, Loidl CF, Creydt VP, Boccoli J, Ibarra C (2007) Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res 1161:106–115PubMedCrossRef
29.
Zurück zum Zitat Tironi-Farinati C, Loidl CF, Boccoli J, Parma Y, Fernandez-Miyakawa ME, Goldstein J (2010) Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities. J Neuroimmunol 222(1-2):48–61PubMedCrossRef Tironi-Farinati C, Loidl CF, Boccoli J, Parma Y, Fernandez-Miyakawa ME, Goldstein J (2010) Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities. J Neuroimmunol 222(1-2):48–61PubMedCrossRef
Metadaten
Titel
Quantitative MRI shows cerebral microstructural damage in hemolytic–uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI
verfasst von
Karin Weissenborn
Eva Bültmann
Frank Donnerstag
Anja M. Giesemann
Friedrich Götz
Hans Worthmann
Meike Heeren
Jan Kielstein
Anke Schwarz
Heinrich Lanfermann
Xiao-Qi Ding
Publikationsdatum
01.07.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Neuroradiology / Ausgabe 7/2013
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-013-1176-3

Weitere Artikel der Ausgabe 7/2013

Neuroradiology 7/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.